Ventricular enlargement and its clinical correlates in the imaging cohort from the adcs mci donepezil/vitamin e study

Alzheimer Disease and Associated Disorders

Volumn 27, Issue 2, 2013, Pages 174-181

  Apostolova, Liana G ^a,b   Babakchanian, Sona ^a,b   Hwang, Kristy S ^a,b   Green, Amity E ^c   Zlatev, Dimitar ^d   Chou, Yi Yu ^e   Decarli, Charlie ^f   Jack, Clifford R ^g   Petersen, Ronald C ^h   Aisen, Paul S ⁱ   Cummings, Jeffrey L ^j   Toga, Arthur W ^a   Thompson, Paul M ^a,b  

^a Department of Neurology ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Monash University   (Australia)

^d STANFORD UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^g MAYO CLINIC   (United States)

^h Mayo Clinic College of Medicine   (United States)

ⁱ LERNER RESEARCH INSTITUTE   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

AD; Alzheimer disease; brain atrophy; imaging; MCI; mild cognitive impairment; MRI; ventricular enlargement

Indexed keywords

AGED; ALZHEIMER DISEASE; ALZHEIMER DISEASE ASSESSMENT SCALE; ARTICLE; BRAIN ATROPHY; BRAIN VENTRICLE DILATATION; COGNITIVE DEFECT; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE ASSOCIATION; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; FRONTAL LOBE; HIPPOCAMPUS; HUMAN; LATERAL BRAIN VENTRICLE; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; PRIORITY JOURNAL; TEMPORAL LOBE;

ACTIVITIES OF DAILY LIVING; AGED; ALZHEIMER DISEASE; CEREBRAL VENTRICLES; CHOLINESTERASE INHIBITORS; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INDANS; MAGNETIC RESONANCE IMAGING; MALE; MILD COGNITIVE IMPAIRMENT; PIPERIDINES; VITAMIN E; VITAMINS;

EID: 84878850825     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e3182677b3d     Document Type: Article

References (25)

1. Carmichael OT, Kuller LH, Lopez OL, et al. Ventricular volume and dementia progression in the Cardiovascular Health Study. Neurobiol Aging. 2007;28:389-397.
2. Chou YY, Lepore N, Saharan P, et al. Ventricular maps in 804 ADNI subjects: correlations with CSF biomarkers and clinical decline. Neurobiol Aging. 2010;31:1386-1400.
3. Jack CR Jr, Shiung MM, Gunter JL, et al. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology. 2004;62:591-600.
4. Chou Y, Lepore N, Avedissian C, et al. Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls. Neuroimage. 2009;46:394-410.
5. Chou YY, Lepore N, de Zubicaray GI, et al. Automated ventricular mapping with multi-atlas fluid image alignment reveals genetic effects in Alzheimer's disease. Neuroimage. 2008;40:615-630.
6. Nestor SM, Rupsingh R, Borrie M, et al. Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database. Brain. 2008;131:2443-2454.
7. Thompson PM, Hayashi KM, De Zubicaray GI, et al. Mapping hippocampal and ventricular change in Alzheimer disease. Neuroimage. 2004;22:1754-1766.
8. Driscoll I, Davatzikos C, An Y, et al. Longitudinal pattern of regional brain volume change differentiates normal aging from MCI. Neurology. 2009;72:1906-1913.
9. Josephs KA, Whitwell JL, Ahmed Z, et al. Beta-amyloid burden is not associated with rates of brain atrophy. Ann Neurol. 2008;63:204-212.
10. Petersen RC, Thomas RG, Grundman M, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005;352:2379-2388.
11. Apostolova LG, Thompson PM, Green AE, et al. 3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI. Hum Brain Mapp. 2010;31:786-797.
12. DeCarli C, Frisoni GB, Clark CM, et al. Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia. Arch Neurol. 2007;64:108-115.
13. Fleisher AS, Sun S, Taylor C, et al. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment. Neurology. 2008;70:191-199.
14. Jack CR Jr, Petersen RC, Grundman M, et al. Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI. Neurobiol Aging. 2008;29:1285-1295.
15. Chou Y, Lepore N, Zubicaray GI, et al. Automated 3D mapping and shape analysis of the lateral ventricles via fluid registration of multiple surface-based atlases. Proc 4th IEEE International Symposium on Biomedical Imaging: From Nano to Macro. 2007;1288-1291.
16. Ferrarini L, Palm WM, Olofsen H, et al. Ventricular shape biomarkers for Alzheimer's disease in clinical MR images. Magn Reson Med. 2008;59:260-267.
17. Chou Y, Lepore N, Avedissian C, et al. Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls. Neuroimage. 2009;46:394-410.
18. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
19. Scheltens P, Launer LJ, Barkhof F, et al. Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability. J Neurol. 1995;242:557-560.
20. Collins DL, Neelin P, Peters TM, et al. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr. 1994;18: 192-205.
21. Shattuck DW, Sandor-Leahy SR, Schaper KA, et al. Magnetic resonance image tissue classification using a partial volume model. Neuroimage. 2001;13:856-876.
22. Thompson PM, Apostolova LG. Computational anatomical methods as applied to ageing and dementia. Br J Radiol. 2007;80(Spec No. 2):S78-S91.
23. Chen P, Ratcliff G, Belle SH, et al. Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology. 2000;55:1847-1853.
24. Evans MC, Barnes J, Nielsen C, et al. Volume changes in Alzheimer's disease and mild cognitive impairment: cognitive associations. Eur Radiol. 2010;20:674-682.
25. Fox NC, Black RS, Gilman S, et al. Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease. Neurology. 2005;64:1563-1572.